SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 143 filers reported holding SAGE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $705,000 | -70.2% | 11,319 | -75.6% | 0.46% | -35.3% |
| Q4 2016 | $2,366,000 | -29.8% | 46,336 | -36.7% | 0.72% | -61.3% |
| Q3 2016 | $3,369,000 | +6.9% | 73,168 | -30.0% | 1.86% | +22.4% |
| Q2 2016 | $3,151,000 | -6.0% | 104,568 | 0.0% | 1.52% | +6.1% |
| Q1 2016 | $3,352,000 | -45.0% | 104,568 | 0.0% | 1.43% | -35.7% |
| Q4 2015 | $6,096,000 | -12.1% | 104,568 | -36.2% | 2.23% | -27.3% |
| Q3 2015 | $6,933,000 | +55.2% | 163,819 | +167.8% | 3.06% | +49.7% |
| Q2 2015 | $4,466,000 | – | 61,180 | – | 2.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |